Henry Schein, Inc. (HSIC) fair value analysis

S&P 500 & Nasdaq · Updated 2026-09-07

Henry Schein, Inc. is a distributor of health care products and services to dental, medical, animal health, and specialty practices. The company operates globally, serving customers in North America, Europe, the Middle East, Africa, and the Asia Pacific region.

Forward Fair Value verdict

Fairly valued

Based on TickrTrends' weekly Forward Fair Value model, HSIC is trading at within about 10% of estimated fair value.

HSIC currently ranks #70 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Fairly valued for 3 consecutive weekly runs.

Last price: $89.81
Sector: Healthcare
12-month range: $63.20–$88.52

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: F
Leverage: Moderate
Margin trend: Stable
Revenue growth: Modest
RSI zone: Neutral
50/200-day trend: Uptrend
52-week position: The top quarter of its range
DCF cross-check: Overvalued

What our data shows for HSIC

Our model validated 17 trailing price-to-earnings windows for HSIC, built from quarterly earnings records.
Shares are trading in the upper third of their 12-month price range of $63.20–$88.52.
The 14-day relative strength index sits at a neutral 50.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for HSIC
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent HSIC news

TickrTrends' derived news-sentiment signal for HSIC is currently leaning positive, computed from recent coverage.

Growth Trajectory and Attractive Valuations Support Henry Schein’s (HSIC) Bullish Thesis (finance.yahoo.com, 2026-08-31)
TickrTrends take: Henry Schein operates in the Healthcare sector and currently trades at valuations that TickrTrends classifies as fairly valued, suggesting the market has already priced in expectations for reasonable growth. The headline points to factors supporting a bullish case, but investors monitoring valuation should watch whether HSIC's growth trajectory delivers results that justify its current price level or whether execution risks emerge. For valuation-focused investors, the fairly valued assessment indicates limited margin of safety at present prices, making fundamental delivery on growth claims particularly important to track.
Henry Schein, Inc. (HSIC) Hits Fresh High: Is There Still Room to Run? (zacks.com, 2026-08-05)
TickrTrends take: Henry Schein operates in the Healthcare sector and currently trades at a valuation that TickrTrends assesses as fairly valued, which suggests the stock's recent move to fresh highs may already reflect much of its near-term upside potential. A valuation-focused reader should monitor whether the company can demonstrate earnings growth sufficient to justify further price appreciation, or whether the stock risks consolidating near current levels if fundamentals fail to keep pace with the advance. The "fairly valued" assessment indicates limited margin of safety at these prices, making follow-through execution on business performance increasingly important for continued upside momentum.
Henry Schein, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:HSIC) 2026-08-05 (seekingalpha.com, 2026-08-05)
TickrTrends take: Henry Schein reported its 2026 second quarter results, providing investors with updated financial performance data relevant to assessing the company's fair value standing. Given that TickrTrends currently rates HSIC as fairly valued, earnings presentations such as this one offer critical information for determining whether that valuation assessment remains appropriate or requires adjustment. Healthcare sector investors evaluating HSIC should monitor whether the company's operational trends and forward guidance support maintaining its current valuation equilibrium or signal a shift in fair value expectations.

What people are saying

Follow the HSIC conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — Healthcare Services Industry Corp (HSIC) shows shifting technical momentum this week. The stock's momentum indicator has moved from a B rating to none, suggesting a loss of directional strength in recent trading activity. The current valuation assessment remains at fairly valued.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is HSIC stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), HSIC is trading at within about 10% of estimated fair value and screens as fairly valued. The exact fair value and discount are available to subscribers.

What is HSIC's TickrTrends verdict?

HSIC's current verdict is Fairly valued, refreshed with every weekly Forward Fair Value run.

How does HSIC compare to other Healthcare stocks?

HSIC ranks #70 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is HSIC overbought or oversold?

HSIC's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →

Head-to-head comparisons

HSIC vs AZTA · HSIC vs BAX · HSIC vs COR · HSIC vs ELV · HSIC vs IQV